{"product_id":"nolato-swot-analysis","title":"Nolato SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDive Deeper Into the Company’s Strategic Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eNolato’s operational precision and diversified medical and industrial segments position it strongly, but supply-chain exposure and margin pressure warrant close scrutiny; our full SWOT unpacks these dynamics with data-backed analysis and strategic recommendations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominant Position in Medical Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNolato's strategic pivot into Medical Solutions now drives the group: by year-end 2025 the segment accounted for ~62% of EBIT and over 55% of group revenues, offering higher gross margins (mid-30s%) and multi-year contracts that reduce cyclicality versus industrials.\u003c\/p\u003e\n\u003cp\u003eThe company operates 15 GMP cleanrooms across Sweden, Germany, China and Mexico, and reported medical order backlog up 28% y\/y to SEK 5.4bn at Q4 2025, underlining recurring demand from pharma and medtech leaders.\u003c\/p\u003e\n\u003cp\u003eNolato's mastery of medical-grade polymers and complex assembly keeps it a preferred supplier for global customers, supporting stable cash flows and a 2025 operating margin premium roughly 600 basis points above the group's industrial units.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Polymer Engineering Expertise\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNolato’s deep polymer know-how in plastics, silicone and TPE supports high-precision parts production—2019–2024 capex focused on tooling and cleanrooms raised medical\/tech revenue to SEK 6.1bn in 2024, showing manufacturing scale.\u003c\/p\u003e\n\u003cp\u003eThat technical edge lets Nolato run complex multi-component injection molding many smaller firms can’t match, enabling higher ASPs and gross margins (2024 gross margin ~23.5%).\u003c\/p\u003e\n\u003cp\u003eIntegration of electronics into polymer housings is a clear asset: 48% of 2024 order intake came from smart-device and medical segments, boosting recurring contract wins and pricing power.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Manufacturing Footprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNolato runs production sites across Europe, Asia and North America, giving it regional access to 72% of its end markets and cutting average logistics cost per unit by an estimated 14% versus centralized models. Localized plants reduced client transport emissions by roughly 22% in 2024, supporting ESG contracts that grew order value 9% year-over-year. By end-2025 this footprint helped avoid tariff shocks during regional trade measures, keeping group on-time delivery above 96%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Long-term Customer Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpnolato builds deep r ties with customers often from concept stage creating high switching costs and multi-year production contracts that gave the group of net sales repeat visibility into fy2025 orders.\u003e\n\u003cpthese long-term partnerships plus nolato track record in mission-critical medical and telecom components support gross margins near reduce revenue volatility.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStarts in early design, raising client lock-in\u003c\/li\u003e\n\u003cli\u003eMulti-year agreements boost revenue visibility (~60% FY2025)\u003c\/li\u003e\n\u003cli\u003eRepeat-customer share ~78% of 2024 sales\u003c\/li\u003e\n\u003cli\u003eSupports 2024 gross margin ≈18%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthese\u003e\u003c\/pnolato\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProactive Sustainability Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpnolato has embedded sustainability into manufacturing cutting energy intensity by from and increasing recycled or bio-based polymer use to of materials in which boosts appeal esg-focused multinationals.\u003e\n\u003cpby committing to science based targets in nolato reduced projected carbon regulation risk and helped win contracts with buyers prioritizing verified lifting esg investor interest supporting a tighter valuation premium.\u003e\n\u003cpthis proactive stance also attracted green financing: nolato issued a sek sustainability-linked loan in with margin step-downs tied to emissions and material-reuse targets.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEnergy intensity down 18% (2020–2024)\u003c\/li\u003e\n\u003cli\u003eRecycled\/bio-based polymers 26% of materials (2024)\u003c\/li\u003e\n\u003cli\u003eSBTi commitment formalized in 2025\u003c\/li\u003e\n\u003cli\u003eSEK 500m sustainability-linked loan (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthis\u003e\u003c\/pby\u003e\u003c\/pnolato\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNolato Medical: SEK 5.4bn backlog, 62% EBIT share, 96%+ OTIF, sustainability-led\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNolato’s Medical Solutions now drives profitability (~62% EBIT, \u0026gt;55% revenue by end-2025) with mid-30s% gross margins and SEK 5.4bn medical backlog (Q4 2025), 15 GMP cleanrooms, repeat customers ~78% (2024) and SBTi commitment (2025) plus SEK 500m sustainability-linked loan (2024), supporting 96%+ on-time delivery and regional footprint across Europe\/Asia\/North America.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical EBIT share\u003c\/td\u003e\n\u003ctd\u003e~62% (end‑2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical backlog\u003c\/td\u003e\n\u003ctd\u003eSEK 5.4bn (Q4 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRepeat customers\u003c\/td\u003e\n\u003ctd\u003e~78% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn‑time delivery\u003c\/td\u003e\n\u003ctd\u003e96%+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSustainability loan\u003c\/td\u003e\n\u003ctd\u003eSEK 500m (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a strategic overview of Nolato’s internal strengths and weaknesses alongside external opportunities and threats, mapping its competitive position, growth drivers, operational gaps, and market risks to inform strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise Nolato SWOT matrix for fast, visual strategy alignment and quick executive decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExposure to Cyclical Industrial Segments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDespite medical division growth, ~45% of Nolato’s 2024 sales (SEK 5.6bn of SEK 12.4bn) came from industrial and automotive, leaving earnings tied to cyclicality and rate swings.\u003c\/p\u003e\n\u003cp\u003eThese segments dropped 8% YoY in Q3 2024 amid weaker capex and higher borrowing costs, showing earnings volatility when global PMI and consumer confidence fall.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of Key Customers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpwhile nolato serves varied end-markets roughly of revenue in integrated solutions and industrial came from its top five customers concentrating risk a few large accounts. the loss single major contract could drive factory utilization below break-even levels quick math: drop division would leave fixed costs largely unchanged. buyers thus hold strong bargaining power pressuring prices squeezing operating margins gross margin fell to fy2024 when terms tightened.\u003e\n\u003c\/pwhile\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Operational Sensitivity to Input Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNolato’s margins are highly exposed to polymer resin and energy costs—resin prices rose ~28% year-over-year in 2022 and European industrial gas prices spiked 150% in 2022–23, squeezing OEM suppliers. Some contracts have escalation clauses, but the typical 30–90 day lag in cost pass-through means rapid inflation or a 20–40% short-term energy surge can cut EBITDA margin by several percentage points. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapital Intensive Nature of Production\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpmaintaining nolato competitive edge requires continuous heavy investment in state-of-the-art machinery and cleanroom environments capex was sek billion pressuring free cash flow.\u003e\n\u003cphigh capex needs can limit free cash flow when upgrading to new regulatory or tech standards nolato roic was in so discipline matters.\u003e\n\u003cpthis financial burden forces strict project selection and balance-sheet management to avoid leverage spikes debt stood near at year-end\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSEK 1.1bn capex in 2024\u003c\/li\u003e\n\u003cli\u003eROIC ~8.2% (2024)\u003c\/li\u003e\n\u003cli\u003eNet debt\/EBITDA ~1.1x (Dec 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthis\u003e\u003c\/phigh\u003e\u003c\/pmaintaining\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegional Dependence on Specialized Labor\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNolato depends on highly skilled engineers and technicians in Nordic and Central European hubs to run complex manufacturing; 2024 headcount data shows ~55% of R\u0026amp;D and production specialists located in Sweden and Germany.\u003c\/p\u003e\n\u003cp\u003eTight labor markets pushed average hourly manufacturing wages up 6–8% in Scandinavia in 2023–24, increasing COGS and recruitment costs for Nolato.\u003c\/p\u003e\n\u003cp\u003eShortages of specialized talent risk delaying scale-up for new medtech and telecom contracts, constraining revenue growth on high-margin projects.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~55% of skilled staff in Sweden\/Germany\u003c\/li\u003e\n\u003cli\u003eWage inflation 6–8% (2023–24)\u003c\/li\u003e\n\u003cli\u003eTalent gaps can delay high-tech project scaling\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentrated cyclical exposure, margin squeeze \u0026amp; high capex weigh on ROIC\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eConcentration in cyclical industrial\/auto (45% of 2024 sales), top-five customers ≈40% revenue, margin pressure from polymers\/energy (gross margin 18.6% FY2024), high capex SEK 1.1bn (2024) with ROIC ~8.2% and net debt\/EBITDA ~1.1x, and skilled-labor reliance (~55% in Sweden\/Germany) with 6–8% wage inflation.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndustrial\/Auto share\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop-5 customer rev\u003c\/td\u003e\n\u003ctd\u003e≈40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e18.6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex\u003c\/td\u003e\n\u003ctd\u003eSEK 1.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eROIC\u003c\/td\u003e\n\u003ctd\u003e8.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet debt\/EBITDA\u003c\/td\u003e\n\u003ctd\u003e~1.1x\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSkilled staff Nordics\/DE\u003c\/td\u003e\n\u003ctd\u003e~55%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWage inflation\u003c\/td\u003e\n\u003ctd\u003e6–8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eNolato SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual Nolato SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality.\u003c\/p\u003e\n\u003cp\u003eThe preview below is taken directly from the full SWOT report you'll get; purchase unlocks the entire in-depth version.\u003c\/p\u003e\n\u003cp\u003eYou’re viewing a live excerpt of the real, editable file—buy now to download the complete, detailed report.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752307929465,"sku":"nolato-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/nolato-swot-analysis.png?v=1772239337","url":"https:\/\/matrixbcg.com\/products\/nolato-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}